DERMA PHARM A/S: Financial statements 2013
CVR: 89453119
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 29,750,969 and a net result of DKK 1,638,506 compared with DKK 1,071,636 the year before. That is an increase of 53.3% compared with the year before. Equity in the 2013 report amounted to DKK 14,647,022. The solvency ratio was 28.4%.
- Gross Profit
- DKK 29,750,969
- Profit/Loss
- DKK 1,638,506
- Equity
- DKK 14,647,022
- Total Assets
- DKK 51,630,200
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 29.8 mio. | 1.6 mio. | 14.6 mio. | - |
| 2012 | - | 19.4 mio. | 1.1 mio. | 15.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 1, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of DERMA PHARM A/S.
As of November 1, 2013, Statsautoriseret revisor Søren Cortsen has stepped down as auditor of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2012. Gross profit came to DKK 19,403,901, and the net result was DKK 1,071,636.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.